These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20189661)

  • 1. Hearing loss in cystic fibrosis.
    Martins LM; Camargos PA; Becker HM; Becker CG; Guimarães RE
    Int J Pediatr Otorhinolaryngol; 2010 May; 74(5):469-73. PubMed ID: 20189661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.
    Geyer LB; Menna Barreto SS; Weigert LL; Teixeira AR
    Braz J Otorhinolaryngol; 2015; 81(6):589-97. PubMed ID: 26480907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hearing status of Robin sequence patients].
    Medard C; François M; Narcy P
    Ann Otolaryngol Chir Cervicofac; 1999 Dec; 116(6):317-21. PubMed ID: 10615523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorineural hearing loss in patients with cystic fibrosis.
    Cheng AG; Johnston PR; Luz J; Uluer A; Fligor B; Licameli GR; Kenna MA; Jones DT
    Otolaryngol Head Neck Surg; 2009 Jul; 141(1):86-90. PubMed ID: 19559964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss in patients with Behçet's disease: an audiological and transient evoked otoacoustic emission study.
    Aslan S; Serarslan G; Savas N; Teksoz E; Dagli S
    J Laryngol Otol; 2010 Jan; 124(1):10-5. PubMed ID: 19785925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies.
    Zwirner P; Wilichowski E
    Laryngoscope; 2001 Mar; 111(3):515-21. PubMed ID: 11224785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory brainstem response and otoacoustic emissions in Duane retraction syndrome.
    Sevik O; Akdogan O; Gocmen ES; Ozcan KM; Yazar Z; Dere H
    Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1167-70. PubMed ID: 18479758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo.
    Aslan S; Serarslan G; Teksoz E; Dagli S
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):409-14. PubMed ID: 20172390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Otoacoustic emissions in patients with retrocochlear dysfunction: a report of five cases.
    Ried EU; Ried EG; Avilés M
    Ear Nose Throat J; 2000 Jun; 79(6):438, 441-4, 446. PubMed ID: 10893834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audiometric manifestations of Waardenburg's syndrome.
    Oysu C; Baserer N; Tinaz M
    Ear Nose Throat J; 2000 Sep; 79(9):704-9. PubMed ID: 11011489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
    Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M
    Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state response audiometry in a group of patients with steeply sloping sensorineural hearing loss.
    Ballay C; Tonini R; Waninger T; Yoon C; Manolidis S
    Laryngoscope; 2005 Jul; 115(7):1243-6. PubMed ID: 15995514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.